MEDWELLAI, INC.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | $264.7K | $290.9K | — |
| Cost of Revenue | — | — | — | $170.9K | $183.8K | — |
| Gross Profit | — | — | — | $93.8K | $107.1K | — |
| Gross Margin | — | — | — | 35.4% | 36.8% | — |
| Operating Expenses | ||||||
| Research & Development | $21.6K | $120.2K | — | $0 | — | — |
| SG&A Expense | $992.4K | $3.4M | $15.6K | $29.0K | $52.0K | $83 |
| Operating Income | $-1.0M | $-3.5M | $-264.8K | $43.4K | $39.0K | — |
| Operating Margin | — | — | — | 16.4% | 13.4% | — |
| Interest Expense | — | — | — | $0 | $-110 | $-150 |
| Pretax Income | $-1.8M | $-5.0M | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — |
| Net Income | $-1.8M | $-5.0M | $-344.4K | $43.4K | $76.4K | $-45.7K |
| Net Margin | — | — | — | 16.4% | 26.3% | — |
| EPS (Basic) | — | — | — | $0.00 | $0.00 | $0.00 |
| EPS (Diluted) | — | — | — | $0.00 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 78.2M | 321.4M | 317.1M | 62.2M | 52.3M | 31.5M |
| Shares Outstanding (Diluted) | 317.3M | 321.4M | 317.1M | 62.2M | 52.3M | 31.5M |
| Dividends Per Share | — | — | — | — | — | — |